Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cheng, Xiang-Shua; b | Zhao, Kun-Penga; b | Jiang, Xiaa | Du, Lai-Linga | Li, Xiao-Honga | Ma, Zhi-Weia | Yao, Juna | Luo, Yua | Duan, Dong-Xiaoa | Wang, Jian-Zhia; * | Zhou, Xin-Wena; *
Affiliations: [a] Department of Pathophysiology, Key Laboratory of Neurological Diseases of Education Ministry of China, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China | [b] Department of Human Anatomy, Institute of Neurobiology, Medical College of Henan University, Kaifeng, China
Correspondence: [*] Correspondence to: Xin-Wen Zhou or Jian-Zhi Wang, Department of Pathophysiology, Key Laboratory of Neurological Diseases of the Education Ministry of China, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. E-mails: zhouxinwen@mail.hust.edu.cn or wangjz@mail.hust.edu.cn.
Abstract: The activity of protein phosptase-2A (PP2A) is significantly decreased in the brains of Alzheimer's disease (AD) patients, but the upstream effectors for regulating PP2A activity are not fully understood. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) is a key enzyme involved in energy metabolism and its gene expression level is reduced in AD brain specimens. Whether Nmnat2 can activate PP2A deserves to be explored. Here, we first measured the level of Nmnat2, Tyr307-phosphorylation of PP2A, and tau phosphorylation in Tg2576 mice. We observed that the mRNA and protein levels of Nmnat2 were significantly decreased with a simultaneous elevation of p-Tyr307-PP2A and tau phosphorylation in Tg2576 mice. Further studies in HEK293 cells with stable expression of human tau441 (HEK293/tau) demonstrated that simultaneous inhibition of PP2A by okadaic acid abolished the Nmnat2-induced tau dephosphorylation. Moreover, we further demonstrated that overexpression of Nmnat2 could activate PP2A with attenuation of tau phosphorylation, whereas downregulation of Nmnat2 by shRNA inhibited PP2A with tau hyperphosphorylation at multiple AD-associated sites. Our data provide the first evidence that Nmnat2 affects tau phosphorylation by regulating PP2A activity, suggesting that Nmnat2 may serve as a potential target in arresting AD-like tau pathologies.
Keywords: Nicotinamide mononucleotide adenylyltransferase 2, phosphorylation, protein phosphatase 2A, tau
DOI: 10.3233/JAD-122173
Journal: Journal of Alzheimer's Disease, vol. 36, no. 1, pp. 185-195, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl